AkzoNobel N.V. recently announced its fourth quarter and full-year 2013 results. Revenue for the year totaled €14,590 million (~ $20,042 million), down 5% compared to 2012, reportedly as a consequence of adverse currency effects and divestments.
Operating income for 2013 (excluding incidentals) came in at €897 million (~ $1,230 billion) vs. €908 million (~ $1,247 billion) in 2012, excluding impairment. Net income attributable to shareholders reached €724 million (~ $994 million), up from €386 million (~ $530 million) in 2012.